Dr. Jeffrey Miller outlines what he considers to be some of the greatest obstacles to developing BiKEs and the new class of molecules called TriKEs, describes his method and what is unique about his approach, details unexpected discoveries, shares advice for introducing novel antibody therapeutics in the clinical setting and talks about what he considers some of the most exciting new developments emerging for bispecific antibody killer engagers. For more information, please visit http://www.PEGSummit.com/Bispecific-Antibodies-For-Oncology/
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana